血清检测Glypican-3对原发性肝细胞癌诊断及疗效评估的临床意义
目的探讨血清检测磷酯酰肌醇蛋白聚糖-3（GPC3）对原发性肝细胞癌（PHC）诊断及疗效评估的临床意义。方法采用双抗夹心ELISA法,对60例PHC,60例转移性肝癌,50例肝硬化,50例慢性病毒性肝炎,20例肝囊肿,20例脂肪肝,20例肝血管瘤,20例药物性肝炎及40例健康人血清中GPC3进行定量检测。同时采用化学发光法检测PHC患者血清中甲胎蛋白水平,并对治疗前后PHC患者血清中GPC3及甲胎蛋白水平进行比较分析。结果 PHC组血清GPC3水平显著高于其他肝病组及健康对照组,差异有统计学意义（P〈0.05）。转移性肝癌、肝硬化及病毒性肝炎组血清GPC3水平显著高于其他良性肝病组和健康对照组,...
Saved in:
| Published in | 南方医科大学学报 Vol. 37; no. 8; pp. 1060 - 1065 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
南方医科大学南方医院肿瘤内科广东 广州 510515
2017
南方医科大学南方医院消化内科,广东 广州 510515%南方医科大学珠江医院肝胆外科,广东 广州,510280%南方医科大学南方医院消化内科,广东 广州,510515%南方医科大学南方医院肿瘤内科广东 广州 510515 |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 目的探讨血清检测磷酯酰肌醇蛋白聚糖-3（GPC3）对原发性肝细胞癌（PHC）诊断及疗效评估的临床意义。方法采用双抗夹心ELISA法,对60例PHC,60例转移性肝癌,50例肝硬化,50例慢性病毒性肝炎,20例肝囊肿,20例脂肪肝,20例肝血管瘤,20例药物性肝炎及40例健康人血清中GPC3进行定量检测。同时采用化学发光法检测PHC患者血清中甲胎蛋白水平,并对治疗前后PHC患者血清中GPC3及甲胎蛋白水平进行比较分析。结果 PHC组血清GPC3水平显著高于其他肝病组及健康对照组,差异有统计学意义（P〈0.05）。转移性肝癌、肝硬化及病毒性肝炎组血清GPC3水平显著高于其他良性肝病组和健康对照组,差异有统计学意义（P〈0.05）。PHC组血清GPC3水平与甲胎蛋白水平及肝功能状况无关。GPC3与甲胎蛋白诊断PHC的阳性率分别为65%和56.7%,两者联合检测可将PHC的诊断率提高至85%。在23例治疗有效的PHC患者中,15例患者血清中GPC3水平较治疗前呈现稳定的下降趋势,而仅有10例患者血清中甲胎蛋白呈现与疗效相似的下降趋势。结论 GPC3与甲胎蛋白联合检测有望提高PHC的早期诊断率,同时血清GPC3的不同阈值或可在PHC及其他各类肝脏疾病的鉴别诊断过程中发挥作用。GPC3具有较甲胎蛋白更优的特异性及灵敏度,或可成为判断PHC治疗疗效的一种特异性血清学标志。 |
|---|---|
| AbstractList | 目的探讨血清检测磷酯酰肌醇蛋白聚糖-3（GPC3）对原发性肝细胞癌（PHC）诊断及疗效评估的临床意义。方法采用双抗夹心ELISA法,对60例PHC,60例转移性肝癌,50例肝硬化,50例慢性病毒性肝炎,20例肝囊肿,20例脂肪肝,20例肝血管瘤,20例药物性肝炎及40例健康人血清中GPC3进行定量检测。同时采用化学发光法检测PHC患者血清中甲胎蛋白水平,并对治疗前后PHC患者血清中GPC3及甲胎蛋白水平进行比较分析。结果 PHC组血清GPC3水平显著高于其他肝病组及健康对照组,差异有统计学意义（P〈0.05）。转移性肝癌、肝硬化及病毒性肝炎组血清GPC3水平显著高于其他良性肝病组和健康对照组,差异有统计学意义（P〈0.05）。PHC组血清GPC3水平与甲胎蛋白水平及肝功能状况无关。GPC3与甲胎蛋白诊断PHC的阳性率分别为65%和56.7%,两者联合检测可将PHC的诊断率提高至85%。在23例治疗有效的PHC患者中,15例患者血清中GPC3水平较治疗前呈现稳定的下降趋势,而仅有10例患者血清中甲胎蛋白呈现与疗效相似的下降趋势。结论 GPC3与甲胎蛋白联合检测有望提高PHC的早期诊断率,同时血清GPC3的不同阈值或可在PHC及其他各类肝脏疾病的鉴别诊断过程中发挥作用。GPC3具有较甲胎蛋白更优的特异性及灵敏度,或可成为判断PHC治疗疗效的一种特异性血清学标志。 目的 探讨血清检测磷酯酰肌醇蛋白聚糖-3(GPC3)对原发性肝细胞癌(PHC)诊断及疗效评估的临床意义.方法 采用双抗夹心ELISA法,对60例PHC,60例转移性肝癌,50例肝硬化,50例慢性病毒性肝炎,20例肝囊肿,20例脂肪肝,20例肝血管瘤,20例药物性肝炎及40例健康人血清中GPC3进行定量检测.同时采用化学发光法检测PHC患者血清中甲胎蛋白水平,并对治疗前后PHC患者血清中GPC3及甲胎蛋白水平进行比较分析.结果 PHC组血清GPC3水平显著高于其他肝病组及健康对照组,差异有统计学意义(P<0.05).转移性肝癌、肝硬化及病毒性肝炎组血清GPC3水平显著高于其他良性肝病组和健康对照组,差异有统计学意义(P<0.05).PHC组血清GPC3水平与甲胎蛋白水平及肝功能状况无关.GPC3与甲胎蛋白诊断PHC的阳性率分别为65%和56.7%,两者联合检测可将PHC的诊断率提高至85%.在23例治疗有效的PHC患者中,15例患者血清中GPC3水平较治疗前呈现稳定的下降趋势,而仅有10例患者血清中甲胎蛋白呈现与疗效相似的下降趋势.结论 GPC3与甲胎蛋白联合检测有望提高PHC的早期诊断率,同时血清GPC3的不同阈值或可在PHC及其他各类肝脏疾病的鉴别诊断过程中发挥作用.GPC3具有较甲胎蛋白更优的特异性及灵敏度,或可成为判断PHC治疗疗效的一种特异性血清学标志. |
| Abstract_FL | Objective To explore the clinical value of detecting serum glypican-3 in the diagnosis and therapeutic effect evaluation of primary hepatocellular carcinoma (PHC). Methods Using sandwich ELISA, we detected serum glypican-3 levels in 60 patients with PHC, 60 with metastatic liver cancer, 50 with liver cirrhosis, 50 with chronic viral hepatitis, 20 with hepatic cyst, 20 with fatty liver, 20 with hepatic hemangioma and 20 with drug-induced hepatitis as well as in 40 healthy subjects (control). We also analyzed the changes in serum levels of glypican-3 and alpha fetoprotein (AFP) in PHC patients after treatment. Results PHC patients had significantly higher serum levels of glypican-3 than patients with other liver diseases and the control subjects (P<0.05). The levels of serum glypican-3 were significantly higher in patients with metastatic liver cancer, liver cirrhosis and viral hepatitis than in those with other benign liver diseases and the control subjects (P<0.05). Glypican-3 level was not associated with AFP level or liver function in PHC patients, in whom the positivity rates for glypican-3 and AFP were 65%and 56.7%, respectively. The detection rate of PHC increased to 85%by a combined detection of AFP and glypican-3. In the 23 PHC patients who responded positively to treatments, serum glypican-3 level showed a steady decline compared with that in 15 patients before treatment, while serum AFP level showed a similar decrease only in 10 patients. Conclusion Combined detection of glypican-3 and AFP is expected to improve the early diagnosis rate of PHC. The different thresholds of serum glypican-3 may play a role in the differential diagnosis of PHC and other various liver diseases. Glypican-3 may serve as a better marker than AFP with a high specificity and sensitivity for evaluating the therapeutic effect in PHC patients. |
| Author | 王媛媛 周陈杰 李静 周玲 李明松 肖冰 |
| AuthorAffiliation | 南方医科大学南方医院肿瘤内科广东广州510515 南方医科大学珠江医院肝胆外科,广东广州510280 南方医科大学南方医院消化内科,广东广州510515 |
| AuthorAffiliation_xml | – name: 南方医科大学南方医院肿瘤内科广东 广州 510515;南方医科大学南方医院消化内科,广东 广州 510515%南方医科大学珠江医院肝胆外科,广东 广州,510280%南方医科大学南方医院消化内科,广东 广州,510515%南方医科大学南方医院肿瘤内科广东 广州 510515 |
| Author_FL | ZHOU Ling LI Jing XIAO Bing WANG Yuanyuan LI Mingsong ZHOU Chenjie |
| Author_FL_xml | – sequence: 1 fullname: WANG Yuanyuan – sequence: 2 fullname: ZHOU Chenjie – sequence: 3 fullname: LI Jing – sequence: 4 fullname: ZHOU Ling – sequence: 5 fullname: LI Mingsong – sequence: 6 fullname: XIAO Bing |
| Author_xml | – sequence: 1 fullname: 王媛媛 周陈杰 李静 周玲 李明松 肖冰 |
| BookMark | eNo9kM1Kw0AUhWdRwVr7ErpykXgnk2SSpRStQkGQ7svkZ2pKndYGsdkVbUWrWFxYUVARF66kLhRa9XGan8cwUnF1OIePcy9nAWVEQ7gILWOQiambqzXZ830hY50SSVU0VVYAUxkMGUMGZf_jeZT3fc8CDRMKmg5ZtJM8daJxL3ruRB_nxXrQ9GwmJBKOJuHlYzi4ijovydF9_HWSHD_EtxfJqB8NX8NBPx7eRNenyag7_X6L77rT8Xv42Y-6g-nkbBHNcVb33fyf5lB5Y71c2JRK28WtwlpJsnUMErEUw1a4ARa3wFRVnTGmAXcN13aU9DvDBtXiDkstqA7lJqWOwSg1TeIC5pzk0Mqs9pAJzkS1UmsctER6sOIEtcBpt63fDcAADCm7NGPt3Yao7nsp3Wx5e6wVVNJpsEZTivwApYF7ew |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1673-4254.2017.08.10 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Value of detection of serum glypican-3 level in diagnosis and therapeutic effect evaluation of primary hepatocellular carcinoma |
| DocumentTitle_FL | Value of detection of serum glypican-3 level in diagnosis and therapeutic effect evaluation of primary hepatocellular carcinoma |
| EndPage | 1065 |
| ExternalDocumentID | dyjydxxb201708010 673157801 |
| GrantInformation_xml | – fundername: 国家消化系统疾病临床医学研究中心科技支撑项目; 广州市科技计划项目 funderid: (2015BAI13B07); (2014Y2-00088) |
| GroupedDBID | --- 2B. 2C~ 2RA 92F 92I 92L ACGFS ALMA_UNASSIGNED_HOLDINGS CQIGP CW9 F5P RPM TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI PSX |
| ID | FETCH-LOGICAL-c610-3b28c2f80bfb09446aaa50fe8ecd23708c04bfdaecd04d7f977d8a77993e01ff3 |
| ISSN | 1673-4254 |
| IngestDate | Thu May 29 04:08:04 EDT 2025 Wed Feb 14 09:57:36 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 8 |
| Keywords | 甲胎蛋白 tumor markers primary hepatocellular carcinoma glypican-3 原发性肝细胞肝癌 alpha fetoprotein 肿瘤标志物 磷酯酰肌醇蛋白聚糖-3 |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c610-3b28c2f80bfb09446aaa50fe8ecd23708c04bfdaecd04d7f977d8a77993e01ff3 |
| Notes | 44-1627/R primary hepatocellular carcinoma;tumor markers;alpha fetoprotein WANG Yuanyuan, ZHOU Chenjie, LI Jing, ZHOU Ling, LI Mingsong, XIAO Bing （1Department of Oncology, 2Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; 3Department of Hepatobiliary Surgery, Zhujiang Hospital Southern Medical University, Guangzhou 510280, China） Objective To explore the clinical value of detecting serum glypican-3 in the diagnosis and therapeutic effect evaluation of primary hepatocellular carcinoma （PHC）. Methods Using sandwich ELISA, we detected serum glypican-3 levels in 60 patients with PHC, 60 with metastatic liver cancer, 50 with liver cirrhosis, 50 with chronic viral hepatitis, 20 with hepatic cyst, 20 with fatty liver, 20 with hepatic hemangioma and 20 with drug-induced hepatitis as well as in 40 healthy subjects （control）. We also analyzed the changes in serum levels of glypican-3 and alpha fetoprotein （AFP） in PHC patients after treatment. Results PHC patients ha |
| PageCount | 6 |
| ParticipantIDs | wanfang_journals_dyjydxxb201708010 chongqing_primary_673157801 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 南方医科大学学报 |
| PublicationTitleAlternate | Journal of Southern Medical University |
| PublicationTitle_FL | Journal of Southern Medical University |
| PublicationYear | 2017 |
| Publisher | 南方医科大学南方医院肿瘤内科广东 广州 510515 南方医科大学南方医院消化内科,广东 广州 510515%南方医科大学珠江医院肝胆外科,广东 广州,510280%南方医科大学南方医院消化内科,广东 广州,510515%南方医科大学南方医院肿瘤内科广东 广州 510515 |
| Publisher_xml | – name: 南方医科大学南方医院消化内科,广东 广州 510515%南方医科大学珠江医院肝胆外科,广东 广州,510280%南方医科大学南方医院消化内科,广东 广州,510515%南方医科大学南方医院肿瘤内科广东 广州 510515 – name: 南方医科大学南方医院肿瘤内科广东 广州 510515 |
| SSID | ssib051370560 ssib006562552 ssj0002923145 ssib002263520 ssib001186833 |
| Score | 2.104535 |
| Snippet | ... 目的 探讨血清检测磷酯酰肌醇蛋白聚糖-3(GPC3)对原发性肝细胞癌(PHC)诊断及疗效评估的临床意义.方法... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 1060 |
| SubjectTerms | 原发性肝细胞肝癌 甲胎蛋白 磷酯酰肌醇蛋白聚糖-3 肿瘤标志物 |
| Title | 血清检测Glypican-3对原发性肝细胞癌诊断及疗效评估的临床意义 |
| URI | http://lib.cqvip.com/qk/91170A/201708/673157801.html https://d.wanfangdata.com.cn/periodical/dyjydxxb201708010 |
| Volume | 37 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANNQK4kUUFWtVijqnsjUfM8nMMbObWAQ9SIXeSj5bRLZVW2h7WnQVrWLxYEVBRTx4knpQaNWf083uz_C9SbIbtUrtJby8vHkf8zIz7w3zoWkXBYuMKIDILQg5JChGYNSCgIa1WJiJHkPvGKs7lq5esydv0CvTbHroQKeyamlpMZyIVnfdV7IfrwIO_Iq7ZP_Ds32mgAAY_AtP8DA89-Rj4nHiGrhYwbOJ5IQzBFyrxDDC5eVbKwvY1dUs4jHi-kQKBLhHhK8AnwgDqaGM6yBHbhLRIJ5DpCTcVhiLCA8xQhBeV1J9wl0sJUBeo-CDGAcxwlGfAMlLYko8SmSdSF3RuCWGE0mxuHQLhoAHVvgJZIlq7KykNErmdmlIHfUEnqA8GgI2UmUIQ8VcuwLYKMJl5T-GhaAauFQkLhEDYEDCkKkLZghlPFeyG2DGgEQhgBGSgHpil8JKkDSrUyz5XlLVHPZv2F9LKW1ds3Cn9FWlc-SANLb6Uyqcoaz0C3-I-ngFBQAQeeMYIec7YoshzHasGvTEtDrG5QfrFG2ZVwYsQ8-vcyiCH3hluw2slrCFGlhRxERfBC6NdPAI3GJp8q8nl8crN1fi5eUQiSAxwY2QB03I5ozfJtUMvLLBqkaVEAVXshgbk3TWj8KZYTl6mdVjwGVikqKuI-8rdki7UGh96R8643kqc_PN2dsQJapNe800aM5W4supo9qRIjEcc_NWfkwbWp07rl3vvW9lWw-yD63s65NBS-5sbneeveusP89aH3v33nS_P-zdf9t99bS3uZZtfOqsr3U3XmYvHvU22zs_Pndft3e2vnS-rWXt9Z3txye0Kd-bqk_WiltQapGNMVJo8shMuR6moS4otYMgYHqa8CSKTagIHuk0TOMAXnUaOynkczEPHAfyjkQ30tQ6qQ0355vJKW3MsOwUsoeEioBRylkIFRvqQIsxjqOHI9povzpmFvLDbnDdpwGjum6MaOeLCpopusC7M394-PReiEa1wwjnE5lntOHFO0vJWQjtF8Nz6sf4CX1fwW8 |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%A1%80%E6%B8%85%E6%A3%80%E6%B5%8BGlypican-3%E5%AF%B9%E5%8E%9F%E5%8F%91%E6%80%A7%E8%82%9D%E7%BB%86%E8%83%9E%E7%99%8C%E8%AF%8A%E6%96%AD%E5%8F%8A%E7%96%97%E6%95%88%E8%AF%84%E4%BC%B0%E7%9A%84%E4%B8%B4%E5%BA%8A%E6%84%8F%E4%B9%89&rft.jtitle=%E5%8D%97%E6%96%B9%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5&rft.au=%E7%8E%8B%E5%AA%9B%E5%AA%9B&rft.au=%E5%91%A8%E9%99%88%E6%9D%B0&rft.au=%E6%9D%8E%E9%9D%99&rft.au=%E5%91%A8%E7%8E%B2&rft.date=2017&rft.pub=%E5%8D%97%E6%96%B9%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E5%8D%97%E6%96%B9%E5%8C%BB%E9%99%A2%E8%82%BF%E7%98%A4%E5%86%85%E7%A7%91%E5%B9%BF%E4%B8%9C+%E5%B9%BF%E5%B7%9E+510515&rft.issn=1673-4254&rft.volume=37&rft.issue=8&rft.spage=1060&rft.epage=1065&rft_id=info:doi/10.3969%2Fj.issn.1673-4254.2017.08.10&rft.externalDocID=dyjydxxb201708010 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91170A%2F91170A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fdyjydxxb%2Fdyjydxxb.jpg |